JP2006507247A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006507247A5 JP2006507247A5 JP2004535518A JP2004535518A JP2006507247A5 JP 2006507247 A5 JP2006507247 A5 JP 2006507247A5 JP 2004535518 A JP2004535518 A JP 2004535518A JP 2004535518 A JP2004535518 A JP 2004535518A JP 2006507247 A5 JP2006507247 A5 JP 2006507247A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- group
- phenyl
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 97
- 229910052799 carbon Inorganic materials 0.000 claims 22
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000001153 fluoro group Chemical group F* 0.000 claims 15
- 125000003545 alkoxy group Chemical group 0.000 claims 13
- 229910052736 halogen Inorganic materials 0.000 claims 13
- 150000002367 halogens Chemical class 0.000 claims 13
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 3
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- -1 alkyl OCOC Chemical compound 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- KJROYZQXANQCCB-UHFFFAOYSA-N 2-(4-methylsulfonylphenyl)-6-(pyridin-2-ylmethoxy)-4-(trifluoromethyl)pyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C(F)(F)F)=CC(OCC=2N=CC=CC=2)=N1 KJROYZQXANQCCB-UHFFFAOYSA-N 0.000 claims 1
- UEGXVPGOZGJIMA-UHFFFAOYSA-N 4-ethyl-2-[(1-methylpyrazol-4-yl)methylamino]-6-(4-methylsulfonylphenyl)pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1NCC=1C=NN(C)C=1 UEGXVPGOZGJIMA-UHFFFAOYSA-N 0.000 claims 1
- GJGCELHMLIVVEN-UHFFFAOYSA-N 4-ethyl-2-[(5-methylpyridin-2-yl)methylamino]-6-(4-methylsulfonylphenyl)pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1NCC1=CC=C(C)C=N1 GJGCELHMLIVVEN-UHFFFAOYSA-N 0.000 claims 1
- OTZWQZBSAJYZDR-UHFFFAOYSA-N 4-ethyl-2-[(6-methylpyridin-3-yl)methoxy]-6-(4-methylsulfonylphenyl)pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1OCC1=CC=C(C)N=C1 OTZWQZBSAJYZDR-UHFFFAOYSA-N 0.000 claims 1
- CXVYZIFUAOQBKB-UHFFFAOYSA-N 4-ethyl-2-[(6-methylpyridin-3-yl)methylamino]-6-(4-methylsulfonylphenyl)pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1NCC1=CC=C(C)N=C1 CXVYZIFUAOQBKB-UHFFFAOYSA-N 0.000 claims 1
- QLEFRAISEMFOGS-UHFFFAOYSA-N 4-ethyl-6-(4-methylsulfonylphenyl)-2-(pyridin-2-ylmethoxy)pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1OCC1=CC=CC=N1 QLEFRAISEMFOGS-UHFFFAOYSA-N 0.000 claims 1
- LLQNNOXVGDGVCI-UHFFFAOYSA-N 4-ethyl-6-(4-methylsulfonylphenyl)-2-(pyridin-2-ylmethylamino)pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1NCC1=CC=CC=N1 LLQNNOXVGDGVCI-UHFFFAOYSA-N 0.000 claims 1
- JPRMYQBDXDYHMB-UHFFFAOYSA-N 4-ethyl-6-(4-methylsulfonylphenyl)-2-[(4-methyl-1,3-thiazol-2-yl)methylamino]pyridine-3-carbonitrile Chemical compound N#CC=1C(CC)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=NC=1NCC1=NC(C)=CS1 JPRMYQBDXDYHMB-UHFFFAOYSA-N 0.000 claims 1
- LSJNJEUKEDFUOS-UHFFFAOYSA-N 4-ethyl-6-(4-methylsulfonylphenyl)-n-(oxan-4-ylmethyl)pyridin-2-amine Chemical compound N=1C(C=2C=CC(=CC=2)S(C)(=O)=O)=CC(CC)=CC=1NCC1CCOCC1 LSJNJEUKEDFUOS-UHFFFAOYSA-N 0.000 claims 1
- WOPITVVKVRKXAR-UHFFFAOYSA-N 4-ethyl-n-[(2-ethyl-1,2,4-triazol-3-yl)methyl]-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound N=1C(C=2C=CC(=CC=2)S(C)(=O)=O)=CC(CC)=CC=1NCC1=NC=NN1CC WOPITVVKVRKXAR-UHFFFAOYSA-N 0.000 claims 1
- ZYYZFEFYWDMJKQ-UHFFFAOYSA-N 4-methyl-n-[(1-methylpyrazol-3-yl)methyl]-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound N=1C(C=2C=CC(=CC=2)S(C)(=O)=O)=CC(C)=CC=1NCC=1C=CN(C)N=1 ZYYZFEFYWDMJKQ-UHFFFAOYSA-N 0.000 claims 1
- TXHSNZYVIKJKHL-UHFFFAOYSA-N 4-methyl-n-[(1-methylpyrazol-4-yl)methyl]-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound N=1C(C=2C=CC(=CC=2)S(C)(=O)=O)=CC(C)=CC=1NCC=1C=NN(C)C=1 TXHSNZYVIKJKHL-UHFFFAOYSA-N 0.000 claims 1
- RHAKELPGMNNZMY-UHFFFAOYSA-N 4-methyl-n-[(2-methylpyrazol-3-yl)methyl]-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound N=1C(C=2C=CC(=CC=2)S(C)(=O)=O)=CC(C)=CC=1NCC1=CC=NN1C RHAKELPGMNNZMY-UHFFFAOYSA-N 0.000 claims 1
- PKHKNWQIBCZJMC-UHFFFAOYSA-N 4-methyl-n-[(3-methyl-1,2-oxazol-4-yl)methyl]-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound CC1=NOC=C1CNC1=CC(C)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 PKHKNWQIBCZJMC-UHFFFAOYSA-N 0.000 claims 1
- JQYGMWSNHGUYFH-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-n-(pyridin-2-ylmethyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C(F)(F)F)=CC(NCC=2N=CC=CC=2)=N1 JQYGMWSNHGUYFH-UHFFFAOYSA-N 0.000 claims 1
- VFQRMDNTBZLTOG-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-n-[(2-methyl-1,2,4-triazol-3-yl)methyl]-4-(trifluoromethyl)pyridin-2-amine Chemical compound CN1N=CN=C1CNC1=CC(C(F)(F)F)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 VFQRMDNTBZLTOG-UHFFFAOYSA-N 0.000 claims 1
- ZRBRLFRIMWOPNI-UHFFFAOYSA-N 6-(4-methylsulfonylphenyl)-n-pentan-3-yl-4-(trifluoromethyl)pyridin-2-amine Chemical compound CCC(CC)NC1=CC(C(F)(F)F)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 ZRBRLFRIMWOPNI-UHFFFAOYSA-N 0.000 claims 1
- IFLNYNOUGIZZSM-AKAXFMLLSA-N C1C[C@@H](C)CC[C@H]1NC1=CC(C(F)(F)F)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 Chemical compound C1C[C@@H](C)CC[C@H]1NC1=CC(C(F)(F)F)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 IFLNYNOUGIZZSM-AKAXFMLLSA-N 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- IMXXUEDKOYSPGU-UHFFFAOYSA-N n-(cyclohexylmethyl)-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C(F)(F)F)=CC(NCC2CCCCC2)=N1 IMXXUEDKOYSPGU-UHFFFAOYSA-N 0.000 claims 1
- KTOVEMBDIBZSDA-UHFFFAOYSA-N n-(cyclopentylmethyl)-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C(F)(F)F)=CC(NCC2CCCC2)=N1 KTOVEMBDIBZSDA-UHFFFAOYSA-N 0.000 claims 1
- CREBKKWJYADUSK-UHFFFAOYSA-N n-[(1,3-dimethylpyrazol-4-yl)methyl]-4-methyl-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound CC1=NN(C)C=C1CNC1=CC(C)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 CREBKKWJYADUSK-UHFFFAOYSA-N 0.000 claims 1
- RULFYBHOHILGIR-UHFFFAOYSA-N n-[(1,3-dimethylpyrazol-4-yl)methyl]-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound CC1=NN(C)C=C1CNC1=CC(C(F)(F)F)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 RULFYBHOHILGIR-UHFFFAOYSA-N 0.000 claims 1
- ZPHKVHNHVVZLMJ-UHFFFAOYSA-N n-[(1,5-dimethylpyrazol-4-yl)methyl]-4-methyl-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound C1=NN(C)C(C)=C1CNC1=CC(C)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 ZPHKVHNHVVZLMJ-UHFFFAOYSA-N 0.000 claims 1
- JVSGYWWKSKBLRR-UHFFFAOYSA-N n-[(1,5-dimethylpyrazol-4-yl)methyl]-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound C1=NN(C)C(C)=C1CNC1=CC(C(F)(F)F)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 JVSGYWWKSKBLRR-UHFFFAOYSA-N 0.000 claims 1
- JOPYSMUAZPPAPM-UHFFFAOYSA-N n-[(2-ethyl-1,2,4-triazol-3-yl)methyl]-4-methyl-6-(4-methylsulfonylphenyl)pyridin-2-amine Chemical compound CCN1N=CN=C1CNC1=CC(C)=CC(C=2C=CC(=CC=2)S(C)(=O)=O)=N1 JOPYSMUAZPPAPM-UHFFFAOYSA-N 0.000 claims 1
- JBPUBVBADITRBO-UHFFFAOYSA-N n-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound CC1=NOC(CNC=2N=C(C=C(C=2)C(F)(F)F)C=2C=CC(=CC=2)S(C)(=O)=O)=N1 JBPUBVBADITRBO-UHFFFAOYSA-N 0.000 claims 1
- UVKYPAUEYUYGBR-UHFFFAOYSA-N n-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound O1C(C)=NC(CNC=2N=C(C=C(C=2)C(F)(F)F)C=2C=CC(=CC=2)S(C)(=O)=O)=N1 UVKYPAUEYUYGBR-UHFFFAOYSA-N 0.000 claims 1
- VKISWSRIBFIRHN-UHFFFAOYSA-N n-cycloheptyl-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C(F)(F)F)=CC(NC2CCCCCC2)=N1 VKISWSRIBFIRHN-UHFFFAOYSA-N 0.000 claims 1
- HOGXDMUYFQWDIN-UHFFFAOYSA-N n-cyclohexyl-6-(4-methylsulfonylphenyl)-4-(trifluoromethyl)pyridin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(C(F)(F)F)=CC(NC2CCCCC2)=N1 HOGXDMUYFQWDIN-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0221443.5A GB0221443D0 (en) | 2002-09-16 | 2002-09-16 | Pyridine derivates |
| PCT/EP2003/011065 WO2004024691A1 (en) | 2002-09-16 | 2003-09-12 | Cox-2 inhibiting pyridine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006507247A JP2006507247A (ja) | 2006-03-02 |
| JP2006507247A5 true JP2006507247A5 (enExample) | 2006-09-28 |
| JP4630063B2 JP4630063B2 (ja) | 2011-02-09 |
Family
ID=9944138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004535518A Expired - Fee Related JP4630063B2 (ja) | 2002-09-16 | 2003-09-12 | Ｃｏｘ−２阻害性ピリジン誘導体 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7446117B2 (enExample) |
| EP (1) | EP1546107B1 (enExample) |
| JP (1) | JP4630063B2 (enExample) |
| KR (1) | KR20050046782A (enExample) |
| CN (1) | CN1681788A (enExample) |
| AR (1) | AR041246A1 (enExample) |
| AT (1) | ATE462694T1 (enExample) |
| AU (1) | AU2003276063A1 (enExample) |
| BR (1) | BR0313718A (enExample) |
| CA (1) | CA2493497A1 (enExample) |
| DE (1) | DE60331931D1 (enExample) |
| ES (1) | ES2343316T3 (enExample) |
| GB (1) | GB0221443D0 (enExample) |
| IL (1) | IL166460A0 (enExample) |
| IS (1) | IS7659A (enExample) |
| MA (1) | MA27436A1 (enExample) |
| MX (1) | MXPA05002886A (enExample) |
| NO (1) | NO20050662L (enExample) |
| NZ (1) | NZ538201A (enExample) |
| PL (1) | PL376023A1 (enExample) |
| RU (1) | RU2005103618A (enExample) |
| TW (1) | TW200404541A (enExample) |
| WO (1) | WO2004024691A1 (enExample) |
| ZA (1) | ZA200501174B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60305053T2 (de) | 2002-08-19 | 2006-08-31 | Glaxo Group Ltd., Greenford | Pyrimidinderivate als selektive cox-2-inhibitoren |
| GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
| WO2005007627A1 (ja) * | 2003-07-18 | 2005-01-27 | Nihon Nohyaku Co., Ltd. | フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤 |
| ES2778846T3 (es) | 2005-11-08 | 2020-08-12 | Vertex Pharma | Moduladores heterocíclicos de transportadores de casete de unión a ATP |
| CN102863432B (zh) | 2007-05-09 | 2016-09-07 | 沃泰克斯药物股份有限公司 | Cftr调节剂 |
| JP5301557B2 (ja) * | 2007-12-04 | 2013-09-25 | エフ．ホフマン−ラ ロシュ アーゲー | イソオキサゾロ−ピリジン誘導体 |
| WO2009076142A2 (en) * | 2007-12-07 | 2009-06-18 | Vertex Pharmaceuticals Incorporated | Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| KR20150063170A (ko) | 2007-12-07 | 2015-06-08 | 버텍스 파마슈티칼스 인코포레이티드 | 3-(6-(1-(2,2-디플루오로벤조[ｄ][1,3]디옥솔-5-일)사이클로프로판카복스아미도)-3-메틸피리딘-2-일)벤조산의 고체 형태 |
| CN106432213A (zh) | 2008-02-28 | 2017-02-22 | 沃泰克斯药物股份有限公司 | 作为cftr调节剂的杂芳基衍生物 |
| EP2767537B1 (en) | 2008-08-06 | 2017-04-12 | Medivation Technologies, Inc. | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| WO2010046780A2 (en) * | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
| US8541403B2 (en) | 2010-02-03 | 2013-09-24 | Biomarin Pharmaceutical Inc. | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency |
| DK2533640T3 (en) | 2010-02-08 | 2017-01-23 | Medivation Technologies Inc | METHODS OF SYNTHESIS OF DIHYDROPYRIDOPHTHALAZINE DERIVATIVES |
| BR112012026255A2 (pt) | 2010-04-07 | 2017-03-14 | Vertex Pharma | composições farmacêuticas de ácido 3-(6-(1-(2-,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e administração das mesmas |
| TWI557123B (zh) | 2010-10-21 | 2016-11-11 | 梅迪維新技術公司 | 結晶型（８Ｓ，９Ｒ）－５－氟－８－（４－氟苯基）－９－（１－甲基－１Ｈ－１，２，４－三唑－５－基）－８，９－二氫－２Ｈ－吡啶并［４，３，２－ｄｅ］呔－３（７Ｈ）－酮甲苯磺酸鹽 |
| CN102464652B (zh) * | 2010-11-02 | 2013-08-28 | 北京欧博方医药科技有限公司 | 咪唑衍生物、制备方法及用途 |
| US8604062B2 (en) | 2011-10-20 | 2013-12-10 | Hoffman-La Roche Inc. | Process for the preparation of isoxazolyl-methoxy nicotinic acids |
| DK2806859T3 (da) | 2012-01-25 | 2019-08-05 | Vertex Pharma | Formuleringer af 3-(6-(1-(2.2-difluorbenzo[d][1,3]dioxol-5-yl) cyclopropancarboxamido)-3-methylpyridin-2-yl)benzoesyre |
| EP3066084A1 (en) * | 2013-11-07 | 2016-09-14 | Medivation Technologies, Inc. | Triazole intermediates useful in the synthesis of protected n-alkyltriazolecarbaldehydes |
| DK3068392T5 (da) | 2013-11-12 | 2021-09-20 | Vertex Pharma | Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme |
| WO2016081556A1 (en) | 2014-11-18 | 2016-05-26 | Vertex Pharmaceuticals Incorporated | Process of conducting high throughput testing high performance liquid chromatography |
| US20220348590A1 (en) * | 2019-09-13 | 2022-11-03 | The Board Institute, Inc. | Cyclooxygenase-2 inhibitors and uses thereof |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149109A (en) | 1962-02-20 | 1964-09-15 | Searle & Co | Certain 4-trifluoromethyl-2-(oxy/thio) pyrimidines |
| GB1121922A (en) | 1966-06-17 | 1968-07-31 | Ici Ltd | Pyrimidine derivatives |
| NL7008625A (enExample) | 1969-06-25 | 1970-12-29 | ||
| JP3682075B2 (ja) | 1993-04-16 | 2005-08-10 | クミアイ化学工業株式会社 | トリアゾール誘導体及び殺虫、殺ダニ剤 |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| RU2139281C1 (ru) | 1993-11-30 | 1999-10-10 | Джи Ди Сирл энд Компани | Пиразолилзамещенный бензолсульфонамид или его фармацевтически приемлемая соль, фармацевтическая композиция, способ лечения от воспаления или связанного с воспалением заболевания |
| DE69532811T2 (de) | 1994-09-09 | 2005-03-17 | Nippon Shinyaku Co., Ltd. | Heterocyclische Derivative und Arzneimittel |
| US5849758A (en) | 1995-05-30 | 1998-12-15 | American Cyanamid Company | Herbicidal 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines |
| EP0723960B1 (en) | 1995-01-26 | 2003-04-02 | Basf Aktiengesellschaft | Herbicidal 2,6-disubstituted pyridines and 2,4-disubstituted pyrimidines |
| US5596008A (en) | 1995-02-10 | 1997-01-21 | G. D. Searle & Co. | 3,4-Diaryl substituted pyridines for the treatment of inflammation |
| US5686470A (en) | 1995-02-10 | 1997-11-11 | Weier; Richard M. | 2, 3-substituted pyridines for the treatment of inflammation |
| US5576338A (en) | 1995-02-15 | 1996-11-19 | Merck Frosst Canada, Inc. | Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis |
| US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| EP0833664A1 (en) | 1995-06-12 | 1998-04-08 | G.D. SEARLE & CO. | Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| US5942516A (en) | 1995-08-02 | 1999-08-24 | Elliott; John Duncan | Endothelin receptor antagonists |
| US6020343A (en) | 1995-10-13 | 2000-02-01 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
| JPH09241161A (ja) | 1996-03-08 | 1997-09-16 | Nippon Shinyaku Co Ltd | 医 薬 |
| GB9607219D0 (en) | 1996-04-04 | 1996-06-12 | Smithkline Beecham Plc | Novel compounds |
| DE19614858A1 (de) | 1996-04-16 | 1997-10-23 | Basf Ag | Herbizide heterocyclisch substituierte Benzoylisothiazole |
| DE69724788T2 (de) | 1996-07-18 | 2004-08-05 | Merck Frosst Canada & Co., Halifax | Substituierte pyridine als selektive cyclooxygenase inhibitoren |
| EP0820996A1 (en) | 1996-07-24 | 1998-01-28 | American Cyanamid Company | Herbicidal cyanopyridines |
| EP1977749A1 (en) | 1996-10-15 | 2008-10-08 | G.D. Searle LLC | Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| TW520362B (en) | 1996-12-05 | 2003-02-11 | Amgen Inc | Substituted pyrimidine compounds and pharmaceutical composition comprising same |
| DE19651099A1 (de) | 1996-12-09 | 1998-06-10 | Consortium Elektrochem Ind | Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung |
| US5972842A (en) | 1996-12-12 | 1999-10-26 | American Cyanamid Company | Herbicidal cyanopyridines |
| DE19708928A1 (de) | 1997-03-05 | 1998-09-10 | Bayer Ag | Substituierte aromatische Aminoverbindungen |
| US6103737A (en) | 1997-07-03 | 2000-08-15 | Dupont Pharmaceuticals Company | Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists |
| CA2303152A1 (en) | 1997-09-05 | 1999-03-18 | Glaxo Group Limited | 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| US5972986A (en) | 1997-10-14 | 1999-10-26 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| EP1030843A4 (en) | 1997-10-27 | 2002-11-06 | Isk Americas Inc | SUBSTITUTED BENZENE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND HERBICIDES AND LEAVING COMPOSITIONS THAT CONTAIN THEM |
| US6121202A (en) | 1997-11-07 | 2000-09-19 | American Cyanamid Company | Thienyloxypyridines and-pyrimidines useful as herbicidal agents |
| JP2000026421A (ja) | 1998-01-29 | 2000-01-25 | Kumiai Chem Ind Co Ltd | ジアリ―ルスルフィド誘導体及び有害生物防除剤 |
| AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| DE19909541A1 (de) | 1998-03-06 | 1999-10-14 | American Cyanamid Co | Herbizide 2-Aryloxy- bzw. 2-Arylthio-6-arylpyrimidine |
| US6306866B1 (en) | 1998-03-06 | 2001-10-23 | American Cyanamid Company | Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents |
| WO1999055668A1 (en) | 1998-04-27 | 1999-11-04 | Kumiai Chemical Industry Co., Ltd. | 3-arylphenyl sulfide derivatives and insecticides and miticides |
| EP1076648B1 (de) | 1998-04-29 | 2006-07-12 | MERCK PATENT GmbH | Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten |
| GB9812522D0 (en) | 1998-06-10 | 1998-08-05 | Smithkline Beecham Plc | Compounds |
| DE19831246A1 (de) | 1998-07-11 | 2000-01-13 | Clariant Gmbh | Verfahren zur Herstellung von Arylpyridinen |
| US6545054B1 (en) | 1999-02-11 | 2003-04-08 | Millennium Pharmaceuticals, Inc. | Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| US6313072B1 (en) | 1999-02-18 | 2001-11-06 | American Cyanamid Company | Herbicidal 2-aryloxy-or 2-arylthio-6-arylpyrimidines |
| DE69915519T2 (de) | 1999-02-27 | 2005-02-03 | Glaxo Group Ltd., Greenford | Pyrazolopyridine |
| JP4570057B2 (ja) | 1999-09-09 | 2010-10-27 | 三菱レイヨン株式会社 | アリールピリジン誘導体の製造法 |
| AU1548101A (en) | 1999-11-24 | 2001-06-04 | Sagami Chemical Research Center | Sphingosine derivatives |
| GB9927844D0 (en) | 1999-11-26 | 2000-01-26 | Glaxo Group Ltd | Chemical compounds |
| CO5261556A1 (es) | 1999-12-08 | 2003-03-31 | Pharmacia Corp | Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico |
| GB9930358D0 (en) | 1999-12-22 | 2000-02-09 | Glaxo Group Ltd | Process for the preparation of chemical compounds |
| IL150368A0 (en) | 1999-12-23 | 2002-12-01 | Nitromed Inc | Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use |
| GB0002336D0 (en) | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
| GB0002312D0 (en) | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
| GB0003224D0 (en) * | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
| KR100521735B1 (ko) | 2000-02-25 | 2005-10-17 | 에프. 호프만-라 로슈 아게 | 아데노신 수용체 조절인자 |
| JP2001252044A (ja) | 2000-03-15 | 2001-09-18 | Healthy Shokuhin Kk | 五大栄養素調合食品薬膳 |
| JP2003531202A (ja) * | 2000-04-25 | 2003-10-21 | ファルマシア・コーポレーション | ３，４−ジ（カルボシクリルまたはヘテロシクリル）チオフェンの位置選択的合成 |
| AU2001259242A1 (en) | 2000-04-28 | 2001-11-12 | Glaxo Group Limited | Process for the preparation of chemical compounds |
| AU2001268711A1 (en) | 2000-06-23 | 2002-01-08 | Bristol-Myers Squibb Pharma Company | Heteroaryl-phenyl substituted factor xa inhibitors |
| BR0112292A (pt) | 2000-06-23 | 2003-06-24 | Bristol Myers Squibb Pharma Co | Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto |
| WO2002007721A2 (en) | 2000-07-20 | 2002-01-31 | Lauras As | Use of cox-2 inhibitors for preventing immunodeficiency |
| GB0021494D0 (en) | 2000-09-01 | 2000-10-18 | Glaxo Group Ltd | Chemical comkpounds |
| FR2814368B1 (fr) | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
| DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| WO2002055484A1 (en) | 2001-01-12 | 2002-07-18 | Takeda Chemical Industries, Ltd. | Biaryl compound, process for producing the same, and agent |
| US7064117B2 (en) | 2001-01-24 | 2006-06-20 | Auckland Uniservices Limited | Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| US6960595B2 (en) | 2001-03-23 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | 5-6 to 5-7 Heterobicycles as factor Xa inhibitors |
| US6756498B2 (en) | 2001-04-27 | 2004-06-29 | Smithkline Beecham Corporation | Process for the preparation of chemical compounds |
| GB0112803D0 (en) | 2001-05-25 | 2001-07-18 | Glaxo Group Ltd | Pyrimidine derivatives |
| GB0112810D0 (en) | 2001-05-25 | 2001-07-18 | Glaxo Group Ltd | Pyrimidine derivatives |
| GB0112802D0 (en) | 2001-05-25 | 2001-07-18 | Glaxo Group Ltd | Pyrimidine derivatives |
| IL159058A0 (en) | 2001-06-12 | 2004-05-12 | Neurogen Corp | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| SE0102439D0 (sv) | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
| GB0119477D0 (en) | 2001-08-09 | 2001-10-03 | Glaxo Group Ltd | Pyrimidine derivatives |
| GB0119472D0 (en) | 2001-08-09 | 2001-10-03 | Astrazeneca Ab | Compounds |
| US6667311B2 (en) | 2001-09-11 | 2003-12-23 | Albany Molecular Research, Inc. | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| GB0206200D0 (en) | 2002-03-15 | 2002-05-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| US6861249B1 (en) | 2002-04-09 | 2005-03-01 | David Kent | Microbial spray for animal waste |
| DE60305053T2 (de) | 2002-08-19 | 2006-08-31 | Glaxo Group Ltd., Greenford | Pyrimidinderivate als selektive cox-2-inhibitoren |
| GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
| GB0227443D0 (en) | 2002-11-25 | 2002-12-31 | Glaxo Group Ltd | Pyrimidine derivatives |
| GB0319037D0 (en) | 2003-08-13 | 2003-09-17 | Glaxo Group Ltd | 7-Azaindole Derivatives |
-
2002
- 2002-09-16 GB GBGB0221443.5A patent/GB0221443D0/en not_active Ceased
-
2003
- 2003-09-12 KR KR1020057004428A patent/KR20050046782A/ko not_active Withdrawn
- 2003-09-12 DE DE60331931T patent/DE60331931D1/de not_active Expired - Lifetime
- 2003-09-12 WO PCT/EP2003/011065 patent/WO2004024691A1/en not_active Ceased
- 2003-09-12 MX MXPA05002886A patent/MXPA05002886A/es not_active Application Discontinuation
- 2003-09-12 BR BR0313718-0A patent/BR0313718A/pt not_active IP Right Cessation
- 2003-09-12 PL PL03376023A patent/PL376023A1/xx not_active Application Discontinuation
- 2003-09-12 US US10/527,799 patent/US7446117B2/en not_active Expired - Fee Related
- 2003-09-12 JP JP2004535518A patent/JP4630063B2/ja not_active Expired - Fee Related
- 2003-09-12 ES ES03795019T patent/ES2343316T3/es not_active Expired - Lifetime
- 2003-09-12 EP EP03795019A patent/EP1546107B1/en not_active Expired - Lifetime
- 2003-09-12 AT AT03795019T patent/ATE462694T1/de not_active IP Right Cessation
- 2003-09-12 RU RU2005103618/04A patent/RU2005103618A/ru not_active Application Discontinuation
- 2003-09-12 CN CNA038218496A patent/CN1681788A/zh active Pending
- 2003-09-12 NZ NZ538201A patent/NZ538201A/en unknown
- 2003-09-12 AU AU2003276063A patent/AU2003276063A1/en not_active Abandoned
- 2003-09-12 CA CA002493497A patent/CA2493497A1/en not_active Abandoned
- 2003-09-12 AR ARP030103312A patent/AR041246A1/es not_active Application Discontinuation
- 2003-09-15 TW TW092125337A patent/TW200404541A/zh unknown
-
2005
- 2005-01-20 IS IS7659A patent/IS7659A/is unknown
- 2005-01-24 IL IL16646005A patent/IL166460A0/xx unknown
- 2005-02-08 NO NO20050662A patent/NO20050662L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501174A patent/ZA200501174B/xx unknown
- 2005-03-16 MA MA28149A patent/MA27436A1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006507247A5 (enExample) | ||
| RU2005103618A (ru) | Ингибирующие циклооксигеназу-2 (цог-2) производные пиридина | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| TWI461423B (zh) | 用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物 | |
| ES2377430T3 (es) | Inhibidores piridílicos de la señalización de hedgehog | |
| CA2829790C (en) | Multisubstituted aromatic compounds as inhibitors of thrombin | |
| JP4120586B2 (ja) | ２−アシルアミノチアゾール誘導体又はその塩 | |
| ES2817902T3 (es) | N-acil-N'-(piridin-2-il) ureas y análogos que presentan actividades anticancerosas y antiproliferativas | |
| ES2316575T3 (es) | Derivado de fenilpiridincarbonilpiperazina. | |
| ES2770026T3 (es) | Derivados de imidazotiazol e imidazopirazina como inhibidores del receptor activado por proteasa 4 (PAR4) para tratar la agregación plaquetaria | |
| JP2005533803A5 (enExample) | ||
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| JP2011515462A5 (enExample) | ||
| JP2008517926A5 (enExample) | ||
| JP2014525444A5 (enExample) | ||
| TW200534853A (en) | Synergistic methods and compositions for treating cancer | |
| JP2004504301A5 (enExample) | ||
| JP2020511452A5 (enExample) | ||
| JP2006500348A5 (enExample) | ||
| CA2585053A1 (en) | Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors | |
| TW201429957A (zh) | 用於激酶調節及其適應症之化合物及方法 | |
| JP2009529059A5 (enExample) | ||
| JPWO2021170109A5 (enExample) | ||
| BR112020027064A2 (pt) | derivados de quinazolina do tipo éter biarílico | |
| JP2012530765A5 (enExample) |